QUBIS
Investor profile
Venture capital
QUBIS has backed 6 European tech companies across 6 funding rounds between 2018 and 2025, joining rounds totalling €27M. Most active in Healthtech and Software. Data as of Nov 2026.
Also recorded as: QUBIS Limited
Deals
6
distinct rounds
Companies
6
backed
Active span
2018–2025
8 yrs
Total round €
€27M
sum of rounds joined
Deals by year
distinct rounds / yearQUBIS — deals by year — interactive chart.
Data table
| QUBIS — deals by year | |
|---|---|
| 2018 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Top sectors
by dealsQUBIS — top sectors — interactive chart.
Data table
| QUBIS — top sectors | |
|---|---|
| Healthtech | 4 |
| Software | 1 |
Stages
by dealsQUBIS — stages — interactive chart.
Data table
| QUBIS — stages | |
|---|---|
| Seed | 3 |
| Other | 2 |
| Series A | 1 |
Countries
by dealsQUBIS — countries — interactive chart.
Data table
| QUBIS — countries | |
|---|---|
| Ireland | 3 |
| UK | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Re-Vana Therapeutics | UK | 1 | €11M |
| CV6 Therapeutics | UK | 1 | €9.4M |
| Sonrai Analytics | Ireland | 1 | €2.4M |
| GenoME Diagnostics | Ireland | 1 | €1.6M |
| AMPLY | Ireland | 1 | €1.5M |
| Liopa | UK | 1 | €803k |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Re-Vana Therapeutics | Series A | €11M | 2022-11 |
| CV6 Therapeutics | Other | €9.4M | 2022-11 |
| Sonrai Analytics | Seed | €2.4M | 2022-06 |
| GenoME Diagnostics | Seed | €1.6M | 2023-03 |
| AMPLY | Seed | €1.5M | 2025-05 |
| Liopa | Other | €803k | 2018-02 |